Post job

Ophthotech main competitors are Philips Healthcare, Corrona, and Insmed.

Competitor Summary. See how Ophthotech compares to its main competitors:

  • Philips Healthcare has the most employees (24,000).
  • Employees at Philips Healthcare earn more than most of the competitors, with an average yearly salary of $85,358.
Work at Ophthotech?
Share your experience

Ophthotech vs competitors

CompanyFounding dateZippia scoreHeadquarters# of LocationsRevenueEmployees
2007
4.5
New York, NY1$210.0M58
-
4.5
Parsippany-Troy Hills, NJ1$6.4M50
2008
4.8
Santa Clara, CA1$167.2M183
1999
4.0
Boston, MA1$10.0M30
1988
4.9
Bridgewater, NJ1$363.7M373
1986
4.2
Incline Village, NV1$30.7M75
1891
4.7
Andover, MA9$6.8B24,000
2000
4.0
Southborough, MA1-176
Histogen
2005
4.0
San Diego, CA1$17.8M19
1989
4.8
Plainsboro, NJ9$1.6B3,700

Rate Ophthotech's competitiveness in the market.

Zippia waving zebra

Ophthotech salaries vs competitors

Among Ophthotech competitors, employees at Philips Healthcare earn the most with an average yearly salary of $85,358.

Compare Ophthotech salaries vs competitors

CompanyAverage salaryHourly salarySalary score
Ophthotech
$46,140$22.18-
Novartis Consumer Health Inc
$49,843$23.96-
SI-BONE
$74,689$35.91-
NICHQ - National Institute for Children's Health Quality
$46,175$22.20-
Insmed
$81,784$39.32-
PDL BioPharma
$48,962$23.54-

Compare Ophthotech job title salaries vs competitors

CompanyHighest salaryHourly salary
Ophthotech
$32,344$15.55
Integra LifeSciences
$38,466$18.49
Insmed
$36,840$17.71
Philips Healthcare
$36,721$17.65
Histogen
$35,172$16.91
Novartis Consumer Health Inc
$33,276$16.00
SI-BONE
$33,232$15.98
PDL BioPharma
$32,905$15.82
NICHQ - National Institute for Children's Health Quality
$32,065$15.42
Corrona
$32,063$15.41

Do you work at Ophthotech?

Does Ophthotech effectively differentiate itself from competitors?

Ophthotech jobs

Ophthotech demographics vs competitors

Compare gender at Ophthotech vs competitors

Job titleMaleFemale
PDL BioPharma46%54%
Integra LifeSciences56%44%
Philips Healthcare63%37%
Ophthotech--
Male
Female
100%
75%
50%
25%
0%
0%
25%
50%
75%
100%

Compare race at Ophthotech vs competitors

CompanyWhiteHispanic or LatinoBlack or African AmericanAsianUnknownDiversity score
58%19%9%11%3%
9.9
54%15%7%19%4%
9.3
56%13%9%16%4%
9.9

Ophthotech and similar companies CEOs

CEOBio
Steven J. Mento
Histogen

William H. Lewis J.d
Insmed

Jan D. de Witte
Integra LifeSciences

Christopher Stone
PDL BioPharma

Frans van Houten
Philips Healthcare

Jeffrey W. Dunn
SI-BONE

Jeffrey Dunn has over thirty years of executive experience, including serving as the CEO of six companies. His medical device experience includes sacroiliac surgery, ankle replacement, and small bone extremity fusion. Jeffrey Dunn has taken one company public, sold all the others to larger public companies, served on numerous boards of directors and is an advisor to other CEOs. Prior to SI-BONE, Inc. Jeffrey Dunn was CEO of INBONE Technologies, which he built into a leading ankle replacement and small bone fusion medical device company. Jeffrey Dunn led the sale of INBONE to Wright Medical in April, 2008. Jeffrey Dunn was the CEO of Active Decisions. Brought in to effect a turnaround, he closed down a major product line and redirected the technology to the ''software as a service'' model. Active Decisions was bought by Knova Software, a public company that was subsequently sold to Consona, a private equity firm. Previously, Jeffrey Dunn was the CEO of Velogic, an Internet performance testing software company. At Velogic, Jeffrey Dunn reinvented and expanded the product line, restructured the management team and created industry partnerships, one of which ultimately led to the acquisition of the company by Keynote Systems. Jeffrey Dunn was also the CEO of EnterpriseLink, a provider of enterprise Internet enablement software. Jeffrey Dunn was recruited to lead a turnaround by the investors. Jeffrey Dunn reinvigorated the company and successfully sold the company for a substantial gain in less than one year. Jeffrey Dunn was also the CEO of AccelGraphics, a 3D graphics systems supplier. Jeffrey Dunn created AccelGraphics by orchestrating a spin out from Kubota Graphics. He built the company into a rapidly growing enterprise (the 8th fastest growing Silicon Valley public company in 1997). The company was subsequently sold to Evans and Sutherland. Jeffrey Dunn has also held executive positions with Evans and Sutherland, Cygnet Systems, Avnet and Xerox. Jeffrey Dunn holds a BA degree from Colgate University and earned an MBA from Babson College.

Ophthotech competitors FAQs

Search for jobs